These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12717666)

  • 1. [Genetic changes in strains of poliovirus type 2 isolated from patients with vaccine-associated paralytic poliomyelitis].
    Sosa-Díaz RY; Más-Lago P; Valdés-Ramírez O; Sarmiento-Pérez L
    Rev Neurol; 2003 May 1-15; 36(9):812-6. PubMed ID: 12717666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
    Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary.
    Kapusinszky B; Molnár Z; Szomor KN; Berencsi G
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):211-7. PubMed ID: 19863665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans.
    Friedrich F
    Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
    Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
    J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
    Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadopoulou I; Levidiotou S; Markoulatos P
    Mol Cell Probes; 2007 Aug; 21(4):267-75. PubMed ID: 17336496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria.
    Korsun N; Kojouharova M; Vladimirova N; Fiore L; Litvinenko I; Buttinelli G; Fiore S; Voynova-Georgieva V; Mladenova Z; Georgieva D
    J Med Virol; 2009 Sep; 81(9):1661-7. PubMed ID: 19626606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
    Strebel PM; Ion-Nedelcu N; Baughman AL; Sutter RW; Cochi SL
    N Engl J Med; 1995 Feb; 332(8):500-6. PubMed ID: 7830731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine.
    Martinez CV; Old MO; Kwock DK; Khan SS; Garcia JJ; Chan CS; Webster R; Falkovitz-Halpern MS; Maldonado YA
    J Infect Dis; 2004 Jul; 190(2):409-16. PubMed ID: 15216480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
    Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
    Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
    Gouandjika I; Rakoto Andrianarivelo M; Akoua-Koffi C; Zeller H; Ehouman A; Morvan JM
    Bull Soc Pathol Exot; 2000 Jul; 93(3):198-201. PubMed ID: 11030057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction.
    Guillot S; Otelea D; Delpeyroux F; Crainic R
    Vaccine; 1994 May; 12(6):503-7. PubMed ID: 8036823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.
    Combiescu M; Guillot S; Persu A; Baicus A; Pitigoi D; Balanant J; Oprisan G; Crainic R; Delpeyroux F; Aubert-Combiescu A
    Arch Virol; 2007; 152(4):727-38. PubMed ID: 17195957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
    Friedrich F; Da-Silva EF; Schatzmayr HG
    Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
    Otelea D; Guillot S; Furione M; Combiescu AA; Balanant J; Candrea A; Crainic R
    Dev Biol Stand; 1993; 78():33-8. PubMed ID: 8099049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
    Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
    Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.